Nutra Pharma Corp (NPHC) income statement
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 64.8%
- Operating margin
- -1017.8%
- Net margin
- -3370.6%
- Return on equity, FY2025
- 12.9%
Financial strength
- Current ratio
- 0.02
- Debt to equity
- -0.59
- Debt to assets
- 2018.7%
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- 5.02
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?